No Detail Found!

Analysis of characteristics and prognosis of multi-drug resistant Pseudomonas aeruginosa pulmonary infection in elderly patients

Author(s)
Geping Qu Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Zhiyan Wang Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Min Shi Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Wei Jiang Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Yu Zhou Department of Clinical Laboratory, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Zhijian Zhang Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital,28 Fuxing Road, Haidian District, Beijing,China
Abstract
This study aimed to analyze the characteristics and prognostic factors of multi-drug resistant Pseudomonas aeruginosa (MDRPA) pulmonary infection in elderly patients. Clinical data from 118 elderly patients diagnosed with MDRPA infections at Chinese PLA General Hospital were retrospectively reviewed. The 118 cases were mainly from ICU (51 cases, 43.22%) and respiratory department (30 cases, 25.42%). Among MDRPA strains isolated, resistance rates were highest for aztreonam (79.66%), ticarcillin (59.32%), and piperacillin (53.39%), and lowest for tobramycin (15.25%), amikacin (16.49%), and gentamicin (19.49%). ROC analysis highlighted ICU admission (AUC=0.718, sensitivity=73.8%, specificity=69.7%) as the strongest predictor. Logistic regression analysis showed that age =68.5 years (P=0.022, OR=6.907, 95%CI:1.320-36.152), history of diabetes and cardiovascular disease (P=0.005, OR=4.147, 95%CI:1.52611.274; P=0.009, OR=3.702, 95%CI:1.387-9.884) and admission to ICU (P<0.001, OR=8.097, 95%CI:3.031-21.635) were independent predictors of poor prognosis in elderly patients with MDRPA pulmonary infection. The primary departments responsible for MDRPA pulmonary infections in elderly patients were the ICU and the Respiratory Department. The resistance situation was severe, particularly for aztreonam, ticarcillin and piperacillin. Admission to ICU was a significant predictor of poor prognosis, while age, history of diabetes and cardiovascular diseases also had a notable impact on prognosis.
Publication Details
Page(s) 875-883
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
prognosis, Characteristics, Elderly patients, Pulmonary infection, Multi-drug resistant Pseudomonas aeruginosa
References
Adelantado Lacasa M,Portillo ME,Lobo Palanco J,Chamorro J,Ezpeleta Baquedano C .2022 .Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa acquired in a spanish intensive care unit: Using diverse typing methods to identify clonal types. , 10(9) : 1791.
Assefa M .2022 .Multi-drug resistant gram-negative bacterial pneumonia: Etiology, risk factors and drug resistance patterns. Pneumonia (Nathan), 14(1) : 4.
Brunker LB,Boncyk CS,Rengel KF,Hughes CG .2023 .Elderly patients and management in intensive care units (ICU): Clinical challenges. Clin. Interv, 18 : 93-112.
De Almeida Silva KCF,Calomino MA,Deutsch G,de Castilho SR,de Paula GR,Esper LMR,Teixeira LA .2017 .Molecular characterization of multidrugresistant (MDR) Pseudomonas aeruginosa isolated in a burn center. , 43(1) : 137-143.
Goto A,Komiya K,Umeki K,Hiramatsu K,Kadota JI K .2023 .Impact of Pseudomonas aeruginosa coverage on the prognosis of elderly patients with communityacquired pneumonia. J. Infect. Chemother., 29(1) : 55-60.
Hernández-Jiménez P,López-Medrano F,Fernández-Ruiz M,Silva JT,Corbella L,San-Juan R,Lizasoain M,DíazRegañón J,Viedma E,Aguado JM .2022 .Risk factors and outcomes for multidrug resistant Pseudomonas aeruginosa Infection in Immunocompromised patients. Antibiotics, 11(11) : 1459.
Ibrahim K,Thwood D,ELgheriani H,Salem M,Elgadiym Z,Zaghdani A,Alhudiri I,Habibi A,Elfahem A,Belaid S,Ermithi O,Almaghrabi M,ELmaryul A,Almadah S,Rayes A,El Meshri SE,El Salabi A,Elzagheid A .2024 .Prevalence of multi-drug resistant bacteria in intensive care units. Libyan J. Med, 19(1) : 2348235.
Kalın G,Alp E,Chouaikhi A,Roger C .2023 .Antimicrobial multidrug resistance: Clinical implications for infection management in critically Ill Patients. , 11(10) : 2575.
Kang JS,Moon C,Mun SJ,Lee JE,Lee SO,Lee S,Lee SH .2021 .Antimicrobial susceptibility trends and risk factors for antimicrobial resistance in Pseudomonas aeruginosa Bacteremia: 12-Year Experience in a Tertiary Hospital in Korea. J. Korean Med, 36(43) : .
Kiyaga S,Kyany' C,Muraya AW,Smith HJ,Mills EG,Kibet C,Mboowa G,Musila L G .2022 .Genetic diversity, distribution and genomic characterization of antibiotic resistance and virulence of Clinical Pseudomonas aeruginosa Strains in Kenya. , 13 : 835403.
Kresken M,Körber-Irrgang B,Korte-Berwanger M,Pfennigwerth N,Gatermann SG,Seifert H .2020 .Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany. Int. J. Antimicrob. Agents, 55(6) : 105959.
Nasrin S,Hegerle N,Sen S,Nkeze J,Sen S,Permala-Booth J,Choi M,Sinclair J,Tapia MD,Johnson JK,Sow SO,Thaden JT,Fowler VG,Krogfelt KA,Brauner A,Protonotariou E,Christaki E,Shindo Y,Kwa AL,Shakoor S,Singh-Moodley A,Perovic O,Jacobs J,Lunguya O,Simon R,Cross AS,Tennant SM .2022 .Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol, 22(1) : 13.
Pan D,Peng P,Fang Y,Lu J,Fang M .2022 .Distribution and drug resistance of pathogenic bacteria and prognosis in patients with septicemia bloodstream infection with renal insufficiency. Infect. Drug Resist, 15 : 4109-4116.
Paul M,Carrara E,Retamar P,Tängdén T,Bitterman R,Bonomo RA,de Waele J,Daikos GL,Akova M,Harbarth S,Pulcini C,Garnacho-Montero J,Seme K,Tumbarello M,Lindemann PC,Gandra S,Yu Y,Bassetti M,Mouton JW,Tacconelli E,Rodríguez-Baño J .2022 .European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine. Clin. Microbiol, 28(4) : 521-547.
.2022 .Chinese expert consensus on the management of lower respiratory tract infections of Pseudomonas aeruginosa in adults (. Zhonghua. Jie. He. He. Hu. Xi. Za. Zhi., 45(8) : 739-752.
Raman G,Avendano EE,Chan J,Merchant S,Puzniak L S .2018 .Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and metaanalysis. Antimicrob. Resist. Infect. Control, 7 : 79.
.2025 .Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition). Zhonghua. Jie. He. He. Hu. Xi. Za. Zhi., 48(1) : 18-34.
Reynolds D and Kollef M .2021 .The Epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: An Update. Drugs, 81(18) : 2117-2131.
Tang S,Xiao Y,Li J,Li D,Wu S,Huang X,Li J,Yang L,Li J,Wang T,Zhang G,Xu Y,Xie Y Y .2024 .Distribution and drug resistance characteristics of pathogenic bacteria in the elderly population in China in 2021. , 55(4) : 989-994.
Theodorakis N,Feretzakis G,Hitas C,Kreouzi M,Kalantzi S,Spyridaki A,Boufeas IZ,Sakagianni A,Paxinou E,Verykios VS,Nikolaou M .1978 .Antibiotic resistance in the elderly: Mechanisms, risk factors and solutions. , 12(10) : .
Van An N,Hoang LH,Le HHL,Thai Son N,Hong LT,Viet TT,Le TD,Thang TB,Vu LH,Nguyen VTH,Xuan Nguyen K VTH .2023 .Distribution and antibiotic resistance characteristics of bacteria isolated from blood culture in a teaching hospital in vietnam during 2014-2021. , 16 : 1677-1692.
Wang Z,Qin RR,Huang L,Sun LY .2018 .Risk factors for carbapenem-resistant Klebsiella pneumonia infection and mortality of Klebsiella pneumonia infection. Chin. Med. J. (Engl)., 131(1) : 56-62.
Yin C,Alam MZ,Fallon JT,Huang W .2024 .Advances in development of novel therapeutic strategies against multi-drug Resistant Pseudomonas aeruginosa. Antibiotics, 13(2) : 119.
Yin Y,Zhao C,Li H,Jin L,Wang Q,Wang R,Zhang Y,Zhang J,Wang H,CARES network H .2021 .Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: A 10-year prospective observational study in China. Eur. J. Clin. Microbiol, 40(4) : 683-690.
Zhang S,Ou J,Tan Y,Yang B,Wu Y,Liu L Y .2023 .Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes. BMC Pulm. Med, 23(1) : 142.
Zhang Y,Li Y,Zeng J,Chang Y,Han S,Zhao J,Fan Y,Xiong Z,Zou X,Wang C,Li B,Li H,Han J,Liu X,Xia Y,Lu B,Cao B B .2020 .Risk factors for mortality of inpatients with Pseudomonas aeruginosa bacteremia in china: impact of resistance profile in the mortality. Infect. Drug Resist, 13 : 4115-4123.
Zhou C,Sun L,Li H,Huang L,Liu X .2023 .Risk factors and mortality of elderly patients with hospitalacquired pneumonia of carbapenem-resistant Klebsiella pneumoniae Infection. , 16 : 6767-6779.
Zhu Y,Huang WE,Yang Q .2022 .Clinical perspective of antimicrobial resistance in bacteria. Infect. Drug Resist, 15 : 735-746.
0

Citations

0

Downloads

116

Views